The membrane form of the type II IL-1 receptor accounts for inhibitory function

Journal of Immunology

Volumn 165, Issue 6, 2000, Pages 3350-3357

  Neumann, D ^a   Kollewe, C ^a   Martin, M U ^a   Boraschi, D ^a  

^a Chemistry Section   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ARTICLE; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034665374     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.6.3350     Document Type: Article

References (41)

1. Biologic basis for interleukin-1 in disease
2. Interleukin-1 receptor antagonist
3. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
4. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types
5. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
6. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
7. A critical role for the interleukin-1 accessory protein in interleukin-1 signaling
8. MyD88: An adaptor that recruits IRAK to the IL-1 receptor complex
9. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity
10. 1RAK: A kinase associated with the interleukin-1 receptor
11. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
12. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness
13. A soluble binding protein specific for interleukin 1β is produced by activated mononuclear cells
14. A soluble form of the interleukin-1 receptor produced by a human B cell line
15. Identification of soluble interleukin-1 binding protein in cell-free supernatants: Evidence for soluble interleukin-1 receptor
16. Purification and characterization of a novel soluble receptor for interleukin-1
17. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist
18. The type II 'receptor' as a decoy target for interleukin-1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor
19. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells
20. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells
21. Regulated expression of release of the IL-1 decoy receptor in human mononuclear phagocytes
22. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1
23. Reactive oxygen intermediates cause rapid release of interleukin-1 decoy receptor from human myelomonocytic cells
24. TNF-α, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells
25. Identification of an interleukin-1β binding protein in human plasma
26. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
27. Elevated levels of shed type II IL-1 receptors in sepsis: Potential role for type II receptor in regulation of IL-1 response
28. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome
29. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis
30. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA
31. Role of metalloproteases in the release of the IL-1 type II decoy receptor
32. The inhibitory activity of interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor
33. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: A surface 'receptor' with anti-interleukin-1 function
34. Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a meylomonocytic context dampens the response to interleukin-1
35. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody
36. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
37. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
38. Characterization of receptors for IL-1α and IL-1β on lymphoid and non lymphoid cells
39. Differential binding of IL-1α and IL-1β to receptors on B and T cells
40. Binding of IL-1β to IL-1R type II at single cell level
41. A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor